🔎 Trials Near Me

Home › Steatotic Liver Disease › Michigan › Ann Arbor

Steatotic Liver Disease clinical trials in Ann Arbor, MI

4 studies for Steatotic Liver Disease are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RecruitingPhase 3
  • 89bio Clinical Study Site, Ann Arbor
  • 89bio Clinical Study Site, Ypsilanti · 7 mi away
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

RecruitingPhase 3
  • 89bio Clinical Study Site, Ypsilanti · 7 mi away
Ages 18 to 80 · All sexes · Updated Oct 5, 2026 · NCT06318169

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

RecruitingPhase 2
  • University of Michigan, Ann Arbor
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT05832229

Thermoacoustic Method for Estimating Liver Fat Fraction

RecruitingObservational studyHealthy volunteers welcome
  • ENDRA Life Sciences, Ann Arbor
Ages 18 and older · All sexes · Updated Jan 7, 2026 · NCT07321925

About Steatotic Liver Disease

Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.

More about Steatotic Liver Disease on MedlinePlus

Steatotic Liver Disease trials in other cities

Other studies in Ann Arbor

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.